VAERS reports by lot

GSK Varicella/Shingles lot XC972: VAERS reports

35 VAERS reports list lot XC972 as a GSK Varicella/Shingles vaccine, received between 2019-05-17 and 2021-11-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
3%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)3127%
Injection-site / Local reaction2926%
Dermatological (non-injection-site)1312%
Gastrointestinal109%
Allergic / Anaphylactic87%
Neurological65%
Musculoskeletal65%
Cardiac / Cardiovascular54%
Respiratory33%
Thrombotic / Hematological11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Missouri5
Pennsylvania5
Illinois5
Texas4
North Carolina2
California2
Wisconsin2
Georgia2
South Carolina1
Ohio1
New Jersey1
Tennessee1

Reports by month received

2019-059
2019-0611
2019-075
2019-085
2019-092
2019-101
2019-121
2021-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.